Can Fite Biopharma Ltd ADR Financial Flexibility Index
Can Fite Biopharma Ltd ADR financial flexibility index. Can Fite Biopharma Ltd ADR (CANF) has a Financial Flexibility Index of -0.67x as of June 2025. Free cash flow of $-2.38 Million (operating CF $-2.38 Million minus capex $500.00) represents -1% of total liabilities ($3.54 Million). See Can Fite Biopharma Ltd ADR free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Can Fite Biopharma Ltd ADR (2011–2025)
Financial flexibility index of Can Fite Biopharma Ltd ADR from 2011 to 2025. Historical Financial Flexibility Index trend for Can Fite Biopharma Ltd ADR across 15 annual periods. Check Can Fite Biopharma Ltd ADR (CANF) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Can Fite Biopharma Ltd ADR Financial Flexibility Index by Year (2011–2025)
Can Fite Biopharma Ltd ADR financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Can Fite Biopharma Ltd ADR. For the full cash flow conversion analysis, see CANF operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.30x | $-9.02 Million | $-9.02 Million | $3.92 Million | ▼ -11.0% |
| 2024 | -2.07x | $-7.63 Million | $-7.64 Million | $3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | $-8.44 Million | $-8.44 Million | $3.75 Million | ▼ -0.4% |
| 2022 | -2.24x | $-10.79 Million | $-10.80 Million | $4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | $-9.85 Million | $-9.86 Million | $5.87 Million | ▲ +51.9% |
| 2020 | -3.49x | $-12.04 Million | $-12.06 Million | $3.45 Million | ▼ -84.7% |
| 2019 | -1.89x | $-10.83 Million | $-10.83 Million | $5.73 Million | ▼ -126.3% |
| 2018 | -0.83x | $-4.12 Million | $-4.16 Million | $4.94 Million | ▲ +58.1% |
| 2017 | -1.99x | $-9.52 Million | $-9.52 Million | $4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | $-8.92 Million | $-8.93 Million | $6.29 Million | ▼ -120.1% |
| 2015 | -0.64x | $-4.61 Million | $-4.65 Million | $7.16 Million | ▲ +70.7% |
| 2014 | -2.20x | $-7.32 Million | $-7.33 Million | $3.33 Million | ▲ +44.5% |
| 2013 | -3.96x | $-8.62 Million | $-8.63 Million | $2.18 Million | ▼ -113.6% |
| 2012 | -1.85x | $-4.34 Million | $-4.35 Million | $2.34 Million | ▲ +45.4% |
| 2011 | -3.40x | $-5.47 Million | $-5.50 Million | $1.61 Million | — |